Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 1696 AL 1710

Role of astrocytes in Alzheimer's disease pathogenesis and the impact of exercise-induced remodeling

Shao J, Deng Q, Feng S, Wu C, Liu X, Yang L.

Biochem Biophys Res Commun. 2024 Nov 5;732:150418. doi: 10.1016/j.bbrc.2024.150418. Epub 2024 Jul 17.

Mesenchymal stem cell therapy for Alzheimer's disease: A novel therapeutic approach for neurodegenerative diseases

Bhatt A, Bhardwaj H, Srivastava P.

Neuroscience. 2024 Sep 13;555:52-68. doi: 10.1016/j.neuroscience.2024.07.019. Epub 2024 Jul 19.

Evolving significance of kinase inhibitors in the management of Alzheimer's disease

Ansari MM, Sahu SK, Singh TG, Singh SRJ, Kaur P.

Eur J Pharmacol. 2024 Sep 15;979:176816. doi: 10.1016/j.ejphar.2024.176816. Epub 2024 Jul 20.

Introduction to the Costs of Alzheimer's Disease and Related Dementias

Webster NJ, Zahodne LB, Ajrouch KJ, Antonucci TC.

J Aging Health. 2024 Oct;36(9):507-509. doi: 10.1177/08982643241265789. Epub 2024 Jul 22.

Advances in Understanding and Managing Alzheimer's Disease: From Pathophysiology to Innovative Therapeutic Strategies

Rathee S, Sen D, Pandey V, Jain SK.

Curr Drug Targets. 2024;25(11):752-774. doi: 10.2174/0113894501320096240627071400.

Progress in mitochondrial and omics studies in Alzheimer's disease research: from molecular mechanisms to therapeutic interventions

Liao Z, Zhang Q, Ren N, Zhao H, Zheng X.

Front Immunol. 2024 Jul 8;15:1418939. doi: 10.3389/fimmu.2024.1418939. eCollection 2024.

Very Early Onset Familial Alzheimer's Disease Due to Mutation in PSEN1 I143T - First Case Report from South Asia

Anandan S, Rajendran SS, Kumar JP, Shajee DS.

Neurol India. 2024 May 1;72(3):652-654. doi: 10.4103/neurol-india.Neurol-India-D-24-00315. Epub 2024 Jun 30.

Implications of liquid-liquid phase separation and ferroptosis in Alzheimer's disease

Wang F, Chen Z, Zhou Q, Sun Q, Zheng N, Chen Z, Lin J, Li B, Li L.

Neuropharmacology. 2024 Nov 15;259:110083. doi: 10.1016/j.neuropharm.2024.110083. Epub 2024 Jul 21.

Editorial: Introduction to the Special Issue on the A4 Study

Aisen P, Sperling R.

J Prev Alzheimers Dis. 2024;11(4):801. doi: 10.14283/jpad.2024.118.

Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study

Papp KV, Maruff P, Rentz DM, Donohue MC, Liu A, Aisen PS, Sperling RA.

J Prev Alzheimers Dis. 2024;11(4):846-856. doi: 10.14283/jpad.2024.137.

Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled Trial

Raman R, Hussen K, Donohue MC, Ernstrom K, Holdridge KC, Langford O, Molina-Henry DP, Pierce AL, Sims JR, Smith A, Yaari R, Aisen PS, Sperling R, Grill JD.

J Prev Alzheimers Dis. 2024;11(4):874-880. doi: 10.14283/jpad.2024.136.

Safety, Efficacy and Clinical Applications of Focused Ultrasound-Mediated Blood Brain Barrier Opening in Alzheimer's Disease: A Systematic Review

Patwardhan A, Wilkinson T, Meng Y, Alhashyan I, Black SE, Lipsman N, Masellis M.

J Prev Alzheimers Dis. 2024;11(4):975-982. doi: 10.14283/jpad.2024.85.

Periodontal Disease and Alzheimer's: Insights from a Systematic Literature Network Analysis

Villar A, Paladini S, Cossatis J.

J Prev Alzheimers Dis. 2024;11(4):1148-1165. doi: 10.14283/jpad.2024.79.

Handedness in Alzheimer's disease: A systematic review

Abuduaini Y, Chen W, Kong XZ.

Brain Res. 2024 Oct 1;1840:149131. doi: 10.1016/j.brainres.2024.149131. Epub 2024 Jul 23.

Role of the gut microbiome in mediating sex-specific differences in the pathophysiology of Alzheimer's disease

Saha P, Sisodia SS.

Neurotherapeutics. 2024 Oct;21(6):e00426. doi: 10.1016/j.neurot.2024.e00426. Epub 2024 Jul 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias